A novel gene transfer strategy that combines promoter and transgene activities for improved tumor cell inhibition.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 12, p. 935, doi. 10.1038/sj.cgt.7700846
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2005 AND VI 12 AND IP 12
Results: 6
1
2
Experimental therapy of allogeneic solid tumors induced in athymic mice with suicide gene-transducing replication-competent foamy virus vectors.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 12, p. 947, doi. 10.1038/sj.cgt.7700855
- By:
- Publication type:
- Article
3
Coexpression of CD40L and CD70 by semiallogenic tumor cells induces anti-tumor immunity.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 12, p. 963, doi. 10.1038/sj.cgt.7700861
- By:
- Publication type:
- Article
4
Vector-based RNA interference against vascular endothelial growth factor-A significantly limits vascularization and growth of prostate cancer in vivo.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 12, p. 926, doi. 10.1038/sj.cgt.7700862
- By:
- Publication type:
- Article
5
Adeno-associated virus vectors: potential applications for cancer gene therapy.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 12, p. 913, doi. 10.1038/sj.cgt.7700876
- By:
- Publication type:
- Article
6
Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 12, p. 954, doi. 10.1038/sj.cgt.7700856
- By:
- Publication type:
- Article